Skip to main content Help with accessibility Skip to main navigation

AVATROMBOPAG tablets (Doptelet®▼) for chronic immune thrombocytopenia

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 26 - Jan - 2023
Body System:
Red
AVATROMBOPAG tablets (Doptelet®▼) for chronic immune thrombocytopenia

The Cheshire and Merseyside Interim Area Prescribing Group recommends the prescribing of AVATROMBOPAG tablets (Doptelet®▼), by specialists only, for primary chronic immune thrombocytopenia (ITP) in accordance with NICE TA853.

NHS Cheshire and Merseyside APPROVED